III.J.23. Medical Countermeasures for Ricin. Develop medical countermeasures against the biological warfare threat of ricin toxin. By FY97, conduct a Milestone 0 transition of a second generation vaccine. By FY99, transition to advanced development a second generation vaccine which will protect 90 percent of the immunized population against an aerosol challenge and will induce minimum reactogenicity in soldiers when immunized (Milestone 1).
Supports: Army Modernization Plan, Medical Annex OProject, Sustain, and Protect the Force by Development of NBC Agent Preventive Measures. Provides for the exploration, demonstration, and validation of biological defense vaccines as outlined by the DEPSECDEF (26 Aug 91) and the Joint Requirements Oversight Council (31 Aug 92).
|STO Manager:||TSO:||TRADOC POC:|
|Dr. Anna Johnson-Winegar||MAJ Mark Seymour||CPT Ensor|